• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HPV 阳性知晓情况对高危型 HPV 初筛中细胞学分流的影响。

The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening.

机构信息

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands.

Dutch National Institute for Public Health and the Environment, Centre for Population Screening, Bilthoven, the Netherlands.

出版信息

J Med Screen. 2019 Dec;26(4):221-224. doi: 10.1177/0969141319864991. Epub 2019 Jul 25.

DOI:10.1177/0969141319864991
PMID:31342879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6854609/
Abstract

OBJECTIVE

Several studies have shown that there is an upward shift in the classification of cervical cytology when high-risk human papillomavirus (hrHPV) status is known to be positive. The Netherlands implemented primary hrHPV screening with reflex cytology as the primary screening test in 2017. Prior to implementation of the new programme, we investigated whether knowledge of hrHPV status influences cytology rating.

METHODS

Using a set of 200 cytology slides that had been previously tested, two pairs of cytotechnicians rated 100 slides per pair twice: first without knowledge of hrHPV status and then, after a wash-out period of two months, with knowledge of hrHPV status.

RESULTS

We found that hrHPV positive slides were more likely to be rated up over the referral threshold (i.e. from negative for intraepithelial lesion or malignancy to atypical squamous cells of undetermined significance+) than hrHPV negative slides at the second review when hrHPV status was known (relative risk = 3.2; 95% confidence interval: 1.3–7.9).

CONCLUSIONS

If the same upward shift in ratings were to be observed in the national programme, it may have implications for referrals of women with low-grade lesions.

摘要

目的

多项研究表明,当已知高危型人乳头瘤病毒(hrHPV)呈阳性时,宫颈细胞学分类会向上转移。荷兰于 2017 年实施了以高风险型 HPV 检测为初筛、以细胞学检查为补充的宫颈癌筛查策略。在实施新方案之前,我们调查了 hrHPV 状态的知晓情况是否会影响细胞学分级。

方法

本研究使用了一组 200 张已检测的细胞学涂片,由两对细胞学技术员每对各重复评估 100 张涂片:第一次评估时不了解 hrHPV 状态,两个月洗脱期后,了解 hrHPV 状态后再次评估。

结果

当知晓 hrHPV 状态时,hrHPV 阳性的涂片在第二次评估时比 hrHPV 阴性的涂片更有可能被评为高于转诊阈值(即从上皮内病变或恶性肿瘤阴性转为不典型鳞状细胞意义不明确+)(相对风险=3.2;95%置信区间:1.3-7.9)。

结论

如果在全国性方案中观察到相同的分级上调,这可能会对低级别病变女性的转诊产生影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7741/6854609/9aa72b45523d/10.1177_0969141319864991-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7741/6854609/9aa72b45523d/10.1177_0969141319864991-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7741/6854609/9aa72b45523d/10.1177_0969141319864991-fig1.jpg

相似文献

1
The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening.HPV 阳性知晓情况对高危型 HPV 初筛中细胞学分流的影响。
J Med Screen. 2019 Dec;26(4):221-224. doi: 10.1177/0969141319864991. Epub 2019 Jul 25.
2
Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.人乳头瘤病毒基因分型与细胞学分流比较,COMPACT 研究:14642 例女性的设计、方法和基线结果。
Cancer Sci. 2018 Jun;109(6):2003-2012. doi: 10.1111/cas.13608. Epub 2018 May 31.
3
Human papillomavirus test with cytology triage in organized screening for cervical cancer.在宫颈癌组织筛查中采用人乳头瘤病毒检测及细胞学分流
Acta Obstet Gynecol Scand. 2016 Nov;95(11):1220-1227. doi: 10.1111/aogs.13013.
4
Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women.在常规实践中通过高危型 HPV 检测进行宫颈癌筛查:高危型 HPV 阳性和细胞学阴性女性一年随访的结果。
J Med Screen. 2014 Mar;21(1):30-7. doi: 10.1177/0969141314522219. Epub 2014 Jan 31.
5
Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.在高危型人乳头瘤病毒(HPV)DNA阳性女性中,比较使用HPV DNA基因分型、HPV E7信使核糖核酸(mRNA)检测和细胞学检查的分诊算法。
J Clin Virol. 2015 Jun;67:59-66. doi: 10.1016/j.jcv.2015.04.004. Epub 2015 Apr 7.
6
Triage of HPV positive women in cervical cancer screening.宫颈癌筛查中HPV阳性女性的分流
J Clin Virol. 2016 Mar;76 Suppl 1(Suppl 1):S49-S55. doi: 10.1016/j.jcv.2015.11.015. Epub 2015 Nov 28.
7
Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.西班牙加泰罗尼亚地区,在诊断出非典型鳞状细胞意义不明确(ASC-US)后,利用 HPV DNA 检测对宫颈上皮内瘤变 2+(CIN2+)进行预测。
BMC Infect Dis. 2012 Jan 26;12:25. doi: 10.1186/1471-2334-12-25.
8
HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study.HPV 检测作为宫颈细胞学边界性或轻度不典型增生的分流筛查:来自哨点研究的结果。
Br J Cancer. 2011 Sep 27;105(7):983-8. doi: 10.1038/bjc.2011.326. Epub 2011 Sep 6.
9
Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.高危型人乳头瘤病毒 DNA 检测作为宫颈癌筛查计划中的主要检测方法:一项基于人群的队列研究。
BJOG. 2013 Sep;120(10):1260-7; discussion 1267-8. doi: 10.1111/1471-0528.12272. Epub 2013 Jun 21.
10
HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.HPV 检测与常规细胞学检查在宫颈癌筛查中的比较:ARTISTIC RCT 的长期随访。
Health Technol Assess. 2019 Jun;23(28):1-44. doi: 10.3310/hta23280.

引用本文的文献

1
Impact of knowledge of human papillomavirus positivity on cervical cytology performance in Latin America.人乳头瘤病毒阳性知识对拉丁美洲宫颈细胞学检查结果的影响。
J Natl Cancer Inst. 2025 Apr 1;117(4):644-652. doi: 10.1093/jnci/djae283.
2
Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study.HPV 疫苗接种女性的筛查结果:来自丹麦试验 23 队列研究的数据。
PLoS One. 2024 Jun 25;19(6):e0306044. doi: 10.1371/journal.pone.0306044. eCollection 2024.
3
Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.

本文引用的文献

1
HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.荷兰宫颈癌筛查人群中的人乳头瘤病毒流行情况(DuSC研究):使用自动化HC2、cobas和Aptima工作流程进行人乳头瘤病毒检测
BMC Cancer. 2016 Nov 28;16(1):922. doi: 10.1186/s12885-016-2961-2.
2
Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy.HPV 状态知识会影响细胞技术专家对最初诊断为上皮内病变或恶性肿瘤阴性的巴氏试验的解释。
Cancer Cytopathol. 2017 Jan;125(1):60-69. doi: 10.1002/cncy.21783. Epub 2016 Oct 12.
3
宫颈细胞学样本显示,人类标志物 FAM19A4/miR124-2 的甲基化水平在腺癌发生前 8 年就有所增加。
Acta Obstet Gynecol Scand. 2024 Feb;103(2):378-386. doi: 10.1111/aogs.14707. Epub 2023 Nov 14.
4
Performance of visual inspection of the cervix with acetic acid (VIA) for triage of HPV screen-positive women: results from the ESTAMPA study.醋酸肉眼观察(VIA)在 HPV 阳性女性筛查中的应用效果:ESTAMPA 研究结果。
Int J Cancer. 2023 Apr 15;152(8):1581-1592. doi: 10.1002/ijc.34384. Epub 2022 Dec 7.
5
Inter- and intraobserver agreement in whole-slide digital ThinPrep samples of low-grade squamous lesions of the cervix uteri with known high-risk HPV status: A multicentric international study.国际多中心研究:已知高危型 HPV 状态的子宫颈低级别鳞状上皮内病变全玻片数字 ThinPrep 样本的观察者间和观察者内一致性。
Cancer Cytopathol. 2022 Dec;130(12):939-948. doi: 10.1002/cncy.22624. Epub 2022 Jul 14.
6
Cytology interpretation after a change to HPV testing in primary cervical screening: Observational study from the English pilot.HPV 检测用于宫颈癌初筛后细胞学判读的变化:英国试点的观察性研究。
Cancer Cytopathol. 2022 Jul;130(7):531-541. doi: 10.1002/cncy.22572. Epub 2022 Apr 4.
HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.
宫颈癌筛查中采用细胞学分流的人乳头瘤病毒DNA检测:披露人乳头瘤病毒感染状况的影响
Cancer Cytopathol. 2015 Dec;123(12):745-54. doi: 10.1002/cncy.21596. Epub 2015 Jul 31.
4
Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial.用于对HPV阳性女性进行分流的知情细胞学检查:嵌套于NTCC随机对照试验中的子研究
J Natl Cancer Inst. 2015 Jan 7;107(2). doi: 10.1093/jnci/dju423. Print 2015 Feb.
5
The Tahoe Study: bias in the interpretation of Papanicolaou test results when human papillomavirus status is known.塔霍研究:当已知人乳头瘤病毒状态时,巴氏试验结果解读中的偏差。
Arch Pathol Lab Med. 2014 Sep;138(9):1182-5. doi: 10.5858/arpa.2012-0115-CP.
6
Effectiveness of two strategies to follow-up ASC-US and LSIL screening results in The Netherlands using repeat cytology with or without additional hrHPV testing: a retrospective cohort study.荷兰采用重复细胞学检查(无论是否附加高危型人乳头瘤病毒检测)对非典型鳞状细胞意义不明确(ASC-US)和低度鳞状上皮内病变(LSIL)筛查结果进行随访的两种策略的有效性:一项回顾性队列研究。
Cancer Causes Control. 2014 Sep;25(9):1141-9. doi: 10.1007/s10552-014-0414-2. Epub 2014 Jun 17.
7
Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure.对高危型人乳头瘤病毒(HPV)DNA检测呈阳性的30岁及以上女性的液基薄层制片(TCT)阴性宫颈涂片进行针对性复查:一项强化质量控制措施
Diagn Cytopathol. 2013 May;41(5):399-403. doi: 10.1002/dc.22829. Epub 2012 Feb 20.
8
Prior knowledge of HPV status improves detection of CIN2+ by cytology screening.HPV 状态的先验知识可提高细胞学筛查对 CIN2+的检出率。
Am J Obstet Gynecol. 2011 Dec;205(6):569.e1-7. doi: 10.1016/j.ajog.2011.06.101. Epub 2011 Jul 13.